Home / Clindamycin / Czechia
CZ ATC J01FF01 · updated 2 Nov 2026
Clindamycin shortage in Czechia
Is there a Clindamycin shortage in Czechia?
Yes. As of 2 Nov 2026, 2 Clindamycin products are reported short in Czechia, the first since 4 Sep 2026. The company estimate for the return is 23 Nov 2026 (latest 31 Dec 2026). Main reason: distribution or logistics.
Also short in United States, Canada, France, Italy, Ireland, Belgium, Switzerland, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | CLINDAMYCIN KABI 150MG/ML 150MG/ML INJ SOL/INF CNC SOL 10X2ML | Fresenius Kabi s.r.o., Praha | 4 Sep 2026 | 31 Dec 2026 | Distribution or logistics Kapacitní/distribuční důvody |
| CZ | DALACIN C 300MG 300MG CPS DUR 16 | Pfizer, spol. s r.o., Praha | 13 Oct 2026 | 23 Nov 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.